COVID-19-Associated Mucormycosis: What Neurologists Should Know?
作者信息
Kulkarni Rahul, Pujari Shripad
机构信息
Department of Neurology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India.
Department of Neurology, Noble Hospital, Pune, Maharashtra, India.
出版信息
Ann Indian Acad Neurol. 2022 May-Jun;25(3):330-331. doi: 10.4103/aian.aian_427_22. Epub 2022 Jun 14.
Abstract
摘要
相似文献
1
COVID-19-Associated Mucormycosis: What Neurologists Should Know?新型冠状病毒肺炎相关毛霉菌病：神经科医生应了解什么？
Ann Indian Acad Neurol. 2022 May-Jun;25(3):330-331. doi: 10.4103/aian.aian_427_22. Epub 2022 Jun 14.
2
COVID-19-associated mucormycosis: Preliminary report from a tertiary eye care centre.COVID-19 相关毛霉病：来自一家三级眼科护理中心的初步报告。
Indian J Ophthalmol. 2021 Dec;69(12):3685-3689. doi: 10.4103/ijo.IJO_2085_21.
3
Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.在伊朗西部 COVID-19 大流行期间，一所教学治疗医院中鼻-眶-脑毛霉菌病发病率的增加：一项观察性研究。
Mycoses. 2021 Nov;64(11):1366-1377. doi: 10.1111/myc.13351. Epub 2021 Jul 31.
4
COVID-19-associated Mucormycosis: A clinico-epidemiological study.COVID-19 相关毛霉菌病：一项临床流行病学研究。
J Diabetes Complications. 2022 Sep;36(9):108284. doi: 10.1016/j.jdiacomp.2022.108284. Epub 2022 Aug 13.
5
Secondary Bacterial Infections in Mucormycosis-COVID-19 Cases: Experience during the Second COVID-19 Wave in India.黏液性毛霉菌病-COVID-19 病例中的继发性细菌感染：印度第二波 COVID-19 期间的经验。
Microbiol Spectr. 2022 Dec 21;10(6):e0091922. doi: 10.1128/spectrum.00919-22. Epub 2022 Oct 27.
6
7
Association of Risk Factors among Nasal and Orbital Mucormycosis in Coronavirus Disease 2019 Infection: A Cross-Sectional Study.2019冠状病毒病感染中鼻眶毛霉菌病的危险因素关联：一项横断面研究
J Curr Ophthalmol. 2023 Apr 29;34(4):460-464. doi: 10.4103/joco.joco_78_22. eCollection 2022 Oct-Dec.
8
Rhino-orbito-cerebral mucormycosis during Covid-19 pandemic- a prospective observational study.Covid-19 大流行期间的鼻-眶-脑毛霉菌病：一项前瞻性观察性研究。
Indian J Med Microbiol. 2023 Nov-Dec;46:100467. doi: 10.1016/j.ijmmb.2023.100467. Epub 2023 Aug 29.
9
Comparative Study of Clinical Severity and Biochemical Markers in Pre COVID-19 and COVID-19 Rhino-Orbito Cerebral Mucormycosis.新冠病毒感染前与新冠病毒感染相关鼻眶脑型毛霉菌病的临床严重程度及生化标志物对比研究
Indian J Otolaryngol Head Neck Surg. 2023 Mar 17;75(3):1-6. doi: 10.1007/s12070-023-03645-0.
10
Serious health threat of mucormycosis during the ongoing COVID-19 pandemic: what dermatologists need to know in this regard.在当前 COVID-19 大流行期间，毛霉菌病带来的严重健康威胁：皮肤科医生在此方面需要了解的内容。
Int J Dermatol. 2022 Aug;61(8):979-981. doi: 10.1111/ijd.16101. Epub 2022 Jan 30.
引用本文的文献
1
Anticoagulation in the management of septic cavernous sinus thrombosis secondary to rhino-orbito-cerebral mucormycosis: A retrospective real-world experience.鼻眶脑毛霉菌病继发感染性海绵窦血栓形成的抗凝治疗：一项回顾性真实世界经验
Curr J Neurol. 2024 Jan 5;23(1):44-58. doi: 10.18502/cjn.v23i1.16432.
本文引用的文献
1
Covid-19 and Mucormycosis Superinfection: Prospective, Obsevational Study in a Single Center.新冠病毒与毛霉菌病二重感染：单中心前瞻性观察研究
Ann Indian Acad Neurol. 2022 May-Jun;25(3):441-448. doi: 10.4103/aian.aian_1097_21. Epub 2022 Jun 9.
2
Epidemic of Mucormycosis in COVID-19 Pandemic: A Position Paper.2019冠状病毒病大流行期间毛霉病疫情：立场文件
Ann Indian Acad Neurol. 2022 Jan-Feb;25(1):7-10. doi: 10.4103/aian.AIAN_421_21. Epub 2021 May 31.
3
Rhino-Orbito-Cerebral Mycosis and COVID-19: From Bad to Worse?鼻-眶-脑型真菌病与新型冠状病毒肺炎：病情会雪上加霜吗？
Ann Indian Acad Neurol. 2022 Jan-Feb;25(1):68-75. doi: 10.4103/aian.aian_463_21. Epub 2021 Aug 23.
4
Risk factors for Coronavirus disease-associated mucormycosis.冠状病毒病相关毛霉菌病的危险因素。
J Infect. 2022 Mar;84(3):383-390. doi: 10.1016/j.jinf.2021.12.039. Epub 2021 Dec 30.
5
Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.COVID-19 大流行期间毛霉菌病的脑血管受累。
J Stroke Cerebrovasc Dis. 2022 Feb;31(2):106231. doi: 10.1016/j.jstrokecerebrovasdis.2021.106231. Epub 2021 Nov 22.
6
COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum.COVID-19 相关的鼻眶脑毛霉菌病：来自印度东部的一项观察性研究，特别强调神经学谱。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102267. doi: 10.1016/j.dsx.2021.102267. Epub 2021 Sep 1.
7
Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.与 COVID-19 大流行期间毛霉菌病流行相关的危险因素。
Int J Infect Dis. 2021 Oct;111:267-270. doi: 10.1016/j.ijid.2021.08.037. Epub 2021 Aug 24.
8
Mucormycosis in COVID-19 pandemic: Risk factors and linkages.2019冠状病毒病大流行中的毛霉病：危险因素及关联
Curr Res Microb Sci. 2021 Dec;2:100057. doi: 10.1016/j.crmicr.2021.100057. Epub 2021 Aug 8.
9
Imaging findings using a combined MRI/CT protocol to identify the "entire iceberg" in post-COVID-19 mucormycosis presenting clinically as only "the tip".采用 MRI/CT 联合方案的影像学发现，可识别出临床仅表现为“冰山一角”的 COVID-19 后毛霉菌病的“全貌”。
Clin Radiol. 2021 Oct;76(10):784.e27-784.e33. doi: 10.1016/j.crad.2021.07.002. Epub 2021 Aug 2.
10
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
Zotero 插件